Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease

Jacobi Medical Center, The Bronx

Queens Hospital Center, Jamaica

Medstar Health, Washington D.C.

Kaiser Permanente Mid-Atlantic States, Largo

The Center for Cancer and Blood Disorders, A Division of American Oncology Partners, PA, Bethesda

The Johns Hopkins University School of Medicine, Baltimore

UNC Health, Chapel Hill

Science 37, Morrisville

East Carolina University, Greenville

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Hughes Spalding, Atlanta

Emory University - Georgia Comprehensive Sickle Cell Center, Atlanta

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta

University of Alabama at Birmingham (UAB), Birmingham

Karmanos Cancer Institute, Detroit

UI Health Sickle Cell Center, Chicago

New England Sickle Cell Institute, UConn Health, Farmington

Robert Wood Johnson Medical School Rutgers, New Brunswick

Newark Beth Israel Medical Center, Newark

Foothills Medical Center, Calgary

St Paul's Hospital Hematology/Oncology Research, Vancouver

Toronto General Hospital, Toronto